Golden Streak Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 10.10 Cr
- Revenue Growth 41.71%
- Profit Growth 2188.25%
- Ebitda 242.48%
- Net Worth 29.05%
- Total Assets 17.31%
About Golden Streak Drugs And Pharmaceuticals
Golden Streak Drugs And Pharmaceuticals Limited (GSDAPL) is a Public Limited Indian Non-Government Company incorporated in India on 06 December 1994 and has a history of 30 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹10.10 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Narasimharao Maram, Vaijayanthi Vontimitta, and Maram Ajay serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TG1994PLC018874
- Company No.
018874
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Dec 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Golden Streak Drugs And Pharmaceuticals Limited offer?
Golden Streak Drugs And Pharmaceuticals Limited offers a wide range of products and services, including Veterinary Medicines, Rafoxanide Powder, Construction Chemical, Calcium Chloride, Cleaning Machine for Food Industry, CIP System, Injectable Products, Industrial Chemicals & Supplies, Silica Gel, Chemical Reagents & Catalysts.
Who are the key members and board of directors at Golden Streak Drugs And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narasimharao Maram  | Managing Director | 06-Dec-1994 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maram Ajay | Director | 01-Jul-2015 | Current |
| Vaijayanthi Vontimitta | Director | 14-Mar-1998 | Current |
Financial Performance of Golden Streak Drugs And Pharmaceuticals.
Golden Streak Drugs And Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.71% increase. The company also saw a substantial improvement in profitability, with a 2188.25% increase in profit. The company's net worth Soared by an impressive increase of 29.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Golden Streak Drugs And Pharmaceuticals?
In 2022, Golden Streak Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Golden Streak Laboratories LimitedNarasimharao Maram, Vaijayanthi Vontimitta and 1 more are mutual person
Charges (Loans)
₹0
₹101.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 9.90 Cr
- Andhra Pradesh State Financial Corporation : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2015 | State Bank Of India | ₹9.90 Cr | Satisfied |
| 17 Apr 2006 | Andhra Pradesh State Financial Corporation | ₹2.00 M | Satisfied |
How Many Employees Work at Golden Streak Drugs And Pharmaceuticals?
Golden Streak Drugs And Pharmaceuticals has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Golden Streak Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Golden Streak Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
